Cardiopulmonary bypass, steroid administration, and surgical injury synergistically impair memory T cell function and antigen presentation

Interactive Cardiovascular and Thoracic Surgery

Volumn 2, Issue 4, 2003, Pages 598-602

  Sano, Tetsuro ^a   Morita, Shigeki ^a   Masuda, Munetaka ^a   Tomita, Yukihiro ^a   Nishida, Takahiro ^a   Tatewaki, Hideki ^a   Yasui, Hisataka ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Antigen specific immunity; Cardiopulmonary bypass; Steroid

Indexed keywords

ANTIGEN; HYDROCORTISONE; PROTEIN DERIVATIVE; STEROID;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; CARDIOPULMONARY BYPASS; CELL FUNCTION; CELL PROLIFERATION; CELLULAR IMMUNITY; ELECTIVE SURGERY; HEART SURGERY; HUMAN; IMMUNE DEFICIENCY; INFLAMMATION; MEASUREMENT; MEMORY CELL; OFF PUMP SURGERY; OPEN HEART SURGERY; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN PURIFICATION; RANDOMIZATION; REVIEW; SURGICAL INJURY; T CELL FUNCTION IMPAIRMENT; T LYMPHOCYTE;

EID: 1642498139     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-9293(03)00168-3     Document Type: Review

References (15)

1. Roth J.A., Golub S.H., Cukingnan R.A., Brazier J., Morton D.L. Cell-mediated immunity is depressed following cardiopulmonary bypass. Ann Thorac Surg. 31:1981;350-356.
2. van Velzen-Blad H., Dijkstra Y.J., Heijnen C.J., Schurink G.A., Zegers B.J., Ballieux R.E. Cardiopulmonary bypass and host defense functions in human beings: II Lymphocyte function. Ann Thorac Surg. 39:1985;212-217.
3. Ide H., Kakiuchi T., Furuta N., Matsumoto H., Sudo K., Furuse A., Asano K. The effect of cardiopulmonary bypass on T cells and their subpopulations. Ann Thorac Surg. 44:1987;277-282.
4. Nguyen D.M., Mulder D.S., Shennib H. Effect of cardiopulmonary bypass on circulating lymphocyte function. Ann Thorac Surg. 53:(4):1992;611-616.
5. Hisatomi K., Isomura T., Kawara T., Yamasitaa M., Hirano A., Yoshida H., Eriguchi N., Kosuga K., Ohishi K. Changes in lymphocyte subsets, mitogen responsiveness, and interleukin-2 production after cardiac operation. J Thorac Cardiovasc Surg. 98:1989;580-591.
6. Tajima K., Yamamoto F., Kawazoe K., Nakatani I., Sakai H., Abe T., Kawashima Y. Cardiopulmonary bypass and cellular immunity: changes in lymphocyte subsets and natural killer cell activity. Ann Thorac Surg. 55:1993;625-630.
7. Markewitz A., Faist E., Weinhold C., Lang S., Endres S., Hultner L., Reichart B. Alterations of cell-mediated immune response following cardiac surgery. Eur J Cardiothorac Surg. 7:1993;193-199.
8. Mayumi H., Zhang Q.W., Nakashima A., Masuda M., Kohno H., Kawachi Y., Yasui H. Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass. Ann Thorac Surg. 63:1997;129-137.
9. Sano T., Morita S., Tominaga R., Masuda M., Tomita Y., Yasutsune T., Yasui H. Adaptive immunity is severely impaired by open-heart surgery. Jpn J Thorac Cardiovasc Surg. 50:2002;201-205.
10. Teoh K.H., Bradley C.A., Gauldie J., Burrows H. Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery. Circulation. 92:1995;II347-II353.
11. Hill G.E., Alonso A., Spurzem J.R., Stammers A.H., Robbins R.A. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg. 110:1995;1658-1662.
12. Jansen N.J., van Oeveren W., van Vliet M., Stoutenbeek C.P., Eysman L., Wildevuur C.R. The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass. Eur J CardioThorac Surg. 5:1991;211-217.
13. Toft P., Christiansen K., Tonnesen E., Nielsen C.H., Lillevang S. Effect of methylprednisolone on the oxidative burst activity, adhesion molecules and clinical outcome following open heart surgery. Scand Cardiovasc J. 31:1997;283-288.
14. Coffin L.H., Shinozaki T., DeMeules J.E., Browdie R.S.D., Morgan J.G. Ineffectiveness of methylpredonisolone in the treatment of pulmonary dysfunction after cardiopulmonary bypass. Am J Surg. 130:1975;555-559.
15. Chaney M.A., Durazo-Arvizu R.A., Nikolov M.P., Blakeman B.P., Bakhos M. Methylprednisolone does not benefit patients undergoing coronary artery bypass grafting and early tracheal extubation. J Thorac Cardiovasc Surg. 121:2001;561-569.